1-8 of 8
Anthony S. Stein
Close
Sort by
Journal Articles

Intensive Induction Chemotherapy versus Hypomethylating Agents in Combination with Venetoclax in NPM1-mutant AML

Jan Philipp Bewersdorf, Shai Shimony, Rory M. Shallis, Yiwen Liu, Guillaume Berton, Eva Johanna Schaefer, Amer M. Zeidan, Aaron D Goldberg, Eytan M. Stein, Guido Marcucci, Rebecca Bystrom, R. Coleman Lindsley, Evan C. Chen, Jorge Miguel Ramos Perez, Anthony S. Stein, Vinod A Pullarkat, Ibrahim Aldoss, Daniel J DeAngelo, Donna S. Neuberg, Richard M. Stone, Sylvain Garciaz, Brian J. Ball, Maximilian Stahl
Journal: Blood Advances
Blood Adv bloodadvances.2024012858.
https://doi.org/10.1182/bloodadvances.2024012858
Published: 2024
Includes: Supplemental data
Journal Articles

Final phase I substudy results of ivosidenib in patients with mutant IDH1 relapsed/refractory myelodysplastic syndrome

Clinical Trials & Observations
Courtney D. D DiNardo, Gail J. Roboz, Justin M Watts, Yazan F Madanat, Gabrielle T. Prince, Praneeth Baratam, Stéphane de Botton, Anthony S. Stein, James M Foran, Martha L. Arellano, David A Sallman, Mohammad Hossain, Dylan M. Marchione, Xiaofei Bai, Prapti A. Patel, Stephanie M. Kapsalis, Guillermo Garcia-Manero, Amir T. Fathi
Journal: Blood Advances
Blood Adv bloodadvances.2023012302.
https://doi.org/10.1182/bloodadvances.2023012302
Published: 2024
Includes: Supplemental data
Journal Articles

Outcomes of allogeneic hematopoietic cell transplantation in adults with fusions associated with Ph-like ALL

Ibrahim Aldoss, Dongyun Yang, Vanina Tomasian, Sally Mokhtari, Ryan Jackson, Zhaohui Gu, Milhan Telatar, Hooi Yew, Monzr M. Al Malki, Amandeep Salhotra, Samer Khaled, Haris Ali, Ahmed Aribi, Karamjeet S. Sandhu, Matthew Mei, Shukaib Arslan, Paul Koller, Andrew Artz, Patricia Aoun, Dongqing Gu, David Snyder, Forrest M. Stewart, Peter Curtin, Anthony S. Stein, Raju Pillai, Guido Marcucci, Stephen J. Forman, Vinod Pullarkat, Ryotaro Nakamura, Michelle Afkhami
Journal: Blood Advances
Blood Adv (2022) 6 (17): 4936–4948.
https://doi.org/10.1182/bloodadvances.2022007597
Published: 2022
Includes: Supplemental data
Journal Articles

Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents

Clinical Trials & Observations
Ibrahim Aldoss, Sanjeet Dadwal, Jianying Zhang, Bernard Tegtmeier, Matthew Mei, Shukaib Arslan, Monzr M. Al Malki, Amandeep Salhotra, Haris Ali, Ahmed Aribi, Karamjeet Sandhu, Samer Khaled, David Snyder, Ryotaro Nakamura, Anthony S. Stein, Stephen J. Forman, Guido Marcucci, Vinod Pullarkat
Journal: Blood Advances
Blood Adv (2019) 3 (23): 4043–4049.
https://doi.org/10.1182/bloodadvances.2019000930
Published: 2019
Journal Articles

Molecular response with blinatumomab in relapsed/refractory B-cell precursor acute lymphoblastic leukemia

Clinical Trials & Observations
Nicola Gökbuget, Hagop M. Kantarjian, Monika Brüggemann, Anthony S. Stein, Ralf C. Bargou, Hervé Dombret, Adele K. Fielding, Leonard Heffner, Françoise Rigal-Huguet, Mark Litzow, Susan O’Brien, Gerhard Zugmaier, Shan Gao, Dirk Nagorsen, Stephen J. Forman, Max S. Topp
Journal: Blood Advances
Blood Adv (2019) 3 (20): 3033–3037.
https://doi.org/10.1182/bloodadvances.2019000457
Published: 2019
Includes: Supplemental data
Journal Articles

MIPSS70+ v2.0 predicts long-term survival in myelofibrosis after allogeneic HCT with the Flu/Mel conditioning regimen

Clinical Trials & Observations
Haris Ali, Ibrahim Aldoss, Dongyun Yang, Sally Mokhtari, Samer Khaled, Ahmed Aribi, Michelle Afkhami, Monzr M. Al Malki, Thai Cao, Matthew Mei, Margaret O’Donnell, Amandeep Salhotra, Vinod Pullarkat, Lixin Yang, Anthony S. Stein, Guido Marcucci, Stephen J. Forman, Ryotaro Nakamura, Raju Pillai, David Snyder
Journal: Blood Advances
Blood Adv (2019) 3 (1): 83–95.
https://doi.org/10.1182/bloodadvances.2018026658
Published: 2019
Includes: Supplemental data
Journal Articles

Exposure-adjusted adverse events comparing blinatumomab with chemotherapy in advanced acute lymphoblastic leukemia

Clinical Trials & Observations
Anthony S. Stein, Richard A. Larson, Andre C. Schuh, William Stevenson, Ewa Lech-Maranda, Qui Tran, Zachary Zimmerman, William Kormany, Max S. Topp
Journal: Blood Advances
Blood Adv (2018) 2 (13): 1522–1531.
https://doi.org/10.1182/bloodadvances.2018019034
Published: 2018
Includes: Supplemental data
Journal Articles

Inotuzumab ozogamicin in adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia: a phase 1/2 study

Clinical Trials & Observations
Daniel J. DeAngelo, Wendy Stock, Anthony S. Stein, Andrei Shustov, Michaela Liedtke, Charles A. Schiffer, Erik Vandendries, Katherine Liau, Revathi Ananthakrishnan, Joseph Boni, A. Douglas Laird, Luke Fostvedt, Hagop M. Kantarjian, Anjali S. Advani
Journal: Blood Advances
Blood Adv (2017) 1 (15): 1167–1180.
https://doi.org/10.1182/bloodadvances.2016001925
Published: 2017
Includes: Supplemental data